JAKARTA – PT Prodia Widyahusada Tbk. (PRDA) has revealed plans to list its business unit, PT Prodia Diagnostic Line (Proline), on the Indonesia Stock Exchange (IDX) through an Initial Public Offering (IPO) scheme.

Andi Wijaya, President Commissioner of PRDA, explained that Proline is targeted for an IPO within the next 2-3 years. This timeframe is considered ideal to strengthen the business fundamentals and enhance the company's competitiveness before entering the capital market.

“Of all Prodia’s business units, Proline will be the first to go public. It is indeed our plan to launch an IPO, but everything must be properly arranged first. So, if everything goes according to plan, we hope it will be on schedule, approximately 2-3 years from now,” said Andi at Prodia Connect in Menteng, Jakarta, on Tuesday (18/2).

As part of its business strengthening strategy, PRDA has acquired a 39% stake in PT Prodia Diagnostic Line from PT Prodia Utama. This acquisition, an affiliated transaction, took place on 27 June 2024. However, with the 39% ownership, PRDA does not have significant influence over strategic decision-making in Proline. (EF/ZH)